We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Itafos Inc | TSXV:IFOS | TSX Venture | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.08 | 5.33% | 1.58 | 1.54 | 1.58 | 1.58 | 1.50 | 1.50 | 91,802 | 20:59:49 |
From Jul 2024 to Aug 2024
CEO Commentary
“We are extremely pleased to report on the significant progress we have made on the execution of our strategic priorities in Q2, 2024. On the back of positive market fundamentals, the Company continues to report strong operational and financial performance,” said David Delaney. “Execution of the H1/NDR project continues, on time and on budget, as we derisk the project for first ore in H1 2025. We are also pleased to announce the sale of our Araxa project which will unlock value associated with our overseas asset portfolio. As we progress through 2024, the Board and Management will continue to focus on creating shareholder value.”
Q2 2024 Financial Highlights
For Q2 2024, the Company’s financial highlights were as follows:
The decrease in the Company’s Q2 2024 financial performance compared to the corresponding period in the prior year was primarily due to lower sales volumes driven by lower production at Conda due to the completion of the large scope turnaround in 2024, which was partially offset by slightly higher realized prices.
The Company’s total capex1 spend in Q2 2024 was $30.2 million compared to $18.1 million in Q2 2023 with the increase primarily due to development activities at H1/NDR and large scope turnaround at Conda, as well as the sulfuric acid plant turnaround at Arraias.
H1 2024 Financial Highlights
For H1 2024, the Company’s financial highlights were as follows:
The decrease in the Company’s H1 2024 financial performance compared to H1 2023 was primarily due to lower realized prices at Conda, which were partially offset by higher sales volumes at Conda and higher sulfuric acid sales at Arraias.
The Company’s total capex spend in H1 2024 was $36.6 million compared to $20.9 million in H1 2023 with the increase primarily due to development activities at H1/NDR and large scope turnaround at Conda, as well as the sulfuric acid plant turnaround at Arraias.
As of June 30, 2024, the Company’s financial highlights were as follows:
Recent Developments
Sale of the Araxá Project
§ On August 5, 2024, the Company announced that it entered into an agreement to sell its 100% interest in its Araxá project to a wholly-owned subsidiary of St George Mining Limited (“St George”) (ASX: SGQ). The sale is structured as a cash and equity transaction. The total purchase price is cash of USD$21,000,000 and securities of St George (the “Transaction”). As a result of the Transaction, St George will indirectly acquire all of the outstanding securities of Itafos Araxá Mineracao E Fertilizantes S.A.
FY 2024 Market and Financial Outlook
Market Outlook
Prices in Q2 2024 were lower than Q1 2024 prices because of the conclusion of the spring season and a market expectation of a significant summer price reset. Market prices at the end Q2 2024 and now into Q3 2024 however, rebounded significantly. The summer price reset was lower than expected due to low summer monoammonium phosphate (“MAP”) stocks and no major adjustments in the North American MAP supply situation. Moving forward, the Company expects minor increases in MAP pricing going into the fall season due to low on-site inventory and a productive fall application season.
Specific factors the Company expects to support pricing in the global phosphate fertilizer markets through the end of 2024 are as follows:
Financial Outlook
The Company maintained its guidance for 2024 as follows:
| (in millions of US Dollars | Projected | |||
| except as otherwise noted) | FY 2024 | |||
| Sales Volumes (thousands of tonnes P2O5)2 | 320-340 | |||
| Corporate selling, general and administrative expenses3 | $17-20 | |||
| Maintenance capex3 | $25-35 | |||
| Growth capex3 | $35-46 |
Q2 and H1 2024 Market Highlights
MAP New Orleans (“NOLA”) prices averaged $558/st in Q2 2024 compared to $511/st in Q2 2023, up 9% year-over-year, and averaged $591/st in H1 2024 compared to $543/st in H1 2023, up 9% year-over-year.
Specific factors driving the year-over-year increase in MAP NOLA prices were as follows:
June 30, 2024, Highlights
As at June 30, 2024, the Company had trailing 12 months Adjusted EBITDA of $125.1 million compared to $131.8 million at the end of 2023 with the decrease primarily due to the same factors that resulted in lower Adjusted EBITDA.
As at June 30, 2024, the Company had net debt of $8.5 million compared to $61.3 million at the end of 2023, with the reduction primarily due to the repayment of principal debt outstanding from free cash flows generated and higher cash and cash equivalents. The Company’s net debt as at June 30, 2024, was comprised of $59.1 million in cash and $66.1 million in debt (gross of deferred financing costs). As at June 30, 2024, and the end of 2023, the Company’s net leverage ratio was 0.1x.
As at June 30, 2024, the Company had liquidity4 of $100.5 million comprised of $59.1 million in cash and $41.4 million in undrawn borrowing capacity under its $80 million asset-based revolving credit facility (“ABL Facility”).
Operations Highlights and Mine Development
Environmental, Health, and Safety (“EHS”)
Conda
In Idaho, the Company continues to build out infrastructure and work towards realizing the H1/NDR project and extending the mine life of Conda to 2037, an estimate confirmed by the updated NI 43-101 Technical Report we received in April of this year. H1/NDR remains on schedule and on budget to deliver first ore from H1/NDR in the second half of 2025.
In Q2 2024, Conda:
In H1 2024, Conda:
Arraias
In Q2 2024, Arraias:
In H1 2024, Arraias:
About Itafos
Itafos is a phosphate and specialty fertilizer company with businesses and projects spanning three continents:
Itafos is a Delaware corporation headquartered in Houston, Texas, with shares trading on the TSX Venture Exchange under the ticker “IFOS”. The Company’s principal shareholder is CL Fertilizers Holding LLC (“CLF”), an affiliate of global private investment firm Castlelake, L.P.
For more information, or to join the Company’s mailing list, please visit www.itafos.com.
Forward-Looking Information
Certain information contained in this news release constitutes forward-looking information, including statements with respect to: the Company’s planned operations and strategies; the timing for the commencement of operations, infrastructure and civil works at H1 / NDR; the expected resource life of H1 / NDR; and economic and market trends with respect to the global agriculture and phosphate fertilizer markets. All information other than information of historical fact is forward-looking information. Statements that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future include, but are not limited to, statements regarding estimates and/or assumptions in respect of the Company’s financial and business outlook are forward-looking information. The use of any of the words “intend”, “anticipate”, “plan”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “would”, “believe”, “predict” and “potential” and similar expressions are intended to identify forward-looking information.
The forward-looking information contained in this news release is based on the opinions, assumptions and estimates of management set out herein, which management believes are reasonable as at the date the statements are made. Those opinions, assumptions and estimates are inherently subject to a variety of risks and uncertainties and other known and unknown factors that could cause actual events or results to differ materially from those projected in the forward-looking information. These include the Company’s expectations and assumptions with respect to the following: commodity prices; operating results; safety risks; changes to the Company’s mineral reserves and resources; risk that timing of expected permitting will not be met; changes to mine development and completion; foreign operations risks; changes to regulation; environmental risks; the impact of weather and climate change; risks related to asset retirement obligations, general economic changes, including inflation and foreign exchange rates; the actions of the Company’s competitors and counterparties; financing, liquidity, credit and capital risks; the loss of key personnel; impairment risks; cybersecurity risks; risks relating to transportation and infrastructure; changes to equipment and suppliers; concentration risks, adverse litigation; changes to permitting and licensing; geo-political risks; loss of land title and access rights; changes to insurance and uninsured risks; the potential for malicious acts; market and stock price volatility; changes to technology, innovation or artificial intelligence; changes to tax laws; the risk of operating in foreign jurisdictions; the risks posed by a controlling shareholder and other conflicts of interest; risks related to reputational damage, the risk associated with epidemics, pandemics and public health; the risks associated with environmental justice; and any risks related to internal controls over financial reporting risks. Readers are cautioned that the foregoing list of risks, uncertainties and assumptions is not exhaustive.
Although the Company has attempted to identify crucial factors that could cause actual actions, events or results to differ materially from those described in the forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. Additional risks and uncertainties affecting the forward-looking information contained in this news release are described in greater detail in the Company’s Annual Information Form and current Management’s Discussion and Analysis available under the Company’s profile on SEDAR+ at www.sedarplus.ca and on the Company’s website at www.itafos.com. There can be no assurance that forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. The reader is cautioned not to place undue reliance on forward-looking information. The Company undertakes no obligation to update forward-looking statements if circumstances or management’s estimates, assumptions or opinions should change, except as required by applicable securities law. The forward-looking information included in this news release is expressly qualified by this cautionary statement and is made as of the date of this news release.
This news release contains future-oriented financial information and financial outlook information (together, “FOFI”) about the Company’s prospective results of operations, including statements regarding expected Adjusted EBITDA, net income, basic earnings per share, maintenance capex, growth capex and free cash flow. FOFI is subject to the same assumptions, risk factors, limitations and qualifications as set forth in the above paragraph. The Company has included the FOFI to provide an outlook of management’s expectations regarding anticipated activities and results, and such information may not be appropriate for other purposes. The Company and management believe that the FOFI has been prepared on a reasonable basis, reflecting management’s reasonable estimates and judgements; however, actual results of operations and the resulting financial results may vary from the amounts set forth herein. Any financial outlook information speaks only as of the date on which it is made and the Company undertakes no obligation to publicly update or revise any financial outlook information except as required by applicable securities laws.
NEITHER THE TSX-V NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX-V) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS NEWS RELEASE.
For further information, please contact:
Matthew O’NeillExecutive Vice President & Chief Financial Officerinvestor@itafos.com713-242-8446
For Media and Investor Relations:irlabsAlyssa BarryPrincipal and Co-Founderalyssa@irlabs.ca1-833-947-5227
Scientific and Technical Information
The scientific and technical information contained in this news release related to Mineral Resources for Conda and Farim has been reviewed and approved by Jerry DeWolfe, Professional Geologist (P.Geo.) with the Association of Professional Engineers and Geoscientists of Alberta. Mr. DeWolfe is a full-time employee of WSP Canada Inc. and is independent of the Company. The scientific and technical information contained in this news release related to Mineral Reserves for Conda and Farim has been reviewed and approved by Terry Kremmel, Professional Engineer (P.E.) licensed by the States of Missouri and North Carolina. Mr. Kremmel is a full-time employee of WSP USA, Inc. and is independent of the Company. The Company’s latest technical report in respect of Conda is entitled, “NI 43-101 Technical Report Itafos Conda Project, Idaho, USA,” with an effective date of July 1, 2023 (the “Conda Technical Report”) and is available under the Company’s website at www.itafos.com and under the Company’s profile on SEDAR+ at www.sedarplus.ca.
Non-IFRS Financial Measures
This press release contains both IFRS and certain non-IFRS measures that management considers to evaluate the Company’s operational and financial performance. Non-IFRS measures are a numerical measure of a company’s performance, that either include or exclude amounts that are not normally included or excluded from the most directly comparable IFRS measures. Management believes that the non-IFRS measures provide useful supplemental information to investors, analysts, lenders and others. In evaluating non-IFRS measures, investors, analysts, lenders and others should consider that non-IFRS measures do not have any standardized meaning under IFRS and that the methodology applied by the Company in calculating such non-IFRS measures may differ among companies and analysts. Non-IFRS measures should not be considered as a substitute for, nor superior to, measures of financial performance prepared in accordance with IFRS. Definitions and reconciliations of non-IFRS measures to the most directly comparable IFRS measures are included below.
DEFINITIONS
The Company defines its non-IFRS measures as follows:
| Non-IFRS measure | Definition | Most directly comparable IFRS measure | Why the Company uses the measure |
| EBITDA | Earnings before interest, taxes, depreciation, depletion and amortization | Net income (loss) and operating income (loss) | EBITDA is a valuable indicator of the Company’s ability to generate operating income |
| Adjusted EBITDA | EBITDA adjusted for non-cash, extraordinary, non-recurring and other items unrelated to the Company’s core operating activities | Net income (loss) and operating income (loss) | Adjusted EBITDA is a valuable indicator of the Company’s ability to generate operating income from its core operating activities normalized to remove the impact of non-cash, extraordinary and non-recurring items. The Company provides guidance on Adjusted EBITDA as useful supplemental information to investors, analysts, lenders, and others |
| Trailing 12 months Adjusted EBITDA | Adjusted EBITDA for the current and preceding three quarters | Net income (loss) and operating income (loss) for the current and preceding three quarters | The Company uses the trailing 12 months Adjusted EBITDA in the calculation of the net leverage ratio (non-IFRS measure) |
| Total capex | Additions to property, plant, and equipment and mineral properties adjusted for additions to asset retirement obligations, additions to right-of-use assets and capitalized interest | Additions to property, plant and equipment and mineral properties | The Company uses total capex in the calculation of total cash capex (non-IFRS measure) |
| Maintenance capex | Portion of total capex relating to the maintenance of ongoing operations | Additions to property, plant and equipment and mineral properties | Maintenance capex is a valuable indicator of the Company’s required capital expenditures to sustain operations at existing levels |
| Growth capex | Portion of total capex relating to the development of growth opportunities | Additions to property, plant and equipment and mineral properties | Growth capex is a valuable indicator of the Company’s capital expenditures related to growth opportunities. |
| Net debt | Debt less cash and cash equivalents plus deferred financing costs (does not consider lease liabilities) | Current debt, long-term debt and cash and cash equivalents | Net debt is a valuable indicator of the Company’s net debt position as it removes the impact of deferring financing costs. |
| Net leverage ratio | Net debt divided by trailing 12 months Adjusted EBITDA | Current debt, long-term debt and cash and cash equivalents; net income (loss) and operating income (loss) for the current and preceding three quarters | The Company’s net leverage ratio is a valuable indicator of its ability to service its debt from its core operating activities. |
| Liquidity | Cash and cash equivalents plus undrawn committed borrowing capacity | Cash and cash equivalents | Liquidity is a valuable indicator of the Company’s liquidity |
| Free cash flow | Cash flows from operating activities, which excludes payment of interest expense, plus cash flows from investing activities | Cash flows from operating activities and cash flows from investing activities | Free cash flow is a valuable indicator of the Company’s ability to generate cash flows from operations after giving effect to required capital expenditures to sustain operations at existing levels. Free cash flow is a valuable indicator of the Company’s cash flow available for debt service or to fund growth opportunities. The Company provides guidance on free cash flow as useful supplemental information to investors, analysts, lenders, and others. |
| Corporate selling, general and administrative expenses | Corporate selling, general and administrative less share-based payment expense. | Selling, general and administrative expenses | The Company uses corporate selling, general and administrative expenses to assess corporate performance. |
EBITDA, ADJUSTED EBITDA AND TRAILING 12 MONTHS ADJUSTED EBITDA
For the three months ended June 30, 2024 and 2023
For the three months ended June 30, 2024, the Company had EBITDA and Adjusted EBITDA by segment as follows:
| (unaudited in thousands of US Dollars) | Conda | Arraias | Developmentandexploration | Corporate | Total | |||||||||||||||
| Net income (loss) | $ | 22,471 | $ | (1,768 | ) | $ | (35 | ) | $ | (4,462 | ) | $ | 16,206 | |||||||
| Finance (income) expense, net | 954 | (206 | ) | — | 2,435 | 3,183 | ||||||||||||||
| Current and deferred income tax expense (recovery) | 7,286 | — | — | (2,062 | ) | 5,224 | ||||||||||||||
| Depreciation and depletion | 5,835 | 494 | 5 | 83 | 6,417 | |||||||||||||||
| EBITDA | $ | 36,546 | $ | (1,480 | ) | $ | (30 | ) | $ | (4,006 | ) | $ | 31,030 | |||||||
| Unrealized foreign exchange (gain) loss | — | 1,039 | (253 | ) | — | 786 | ||||||||||||||
| Share-based payment expense | — | — | — | 435 | 435 | |||||||||||||||
| Transaction costs | — | — | — | — | — | |||||||||||||||
| Other (income) expense, net | 653 | (57 | ) | 3 | (40 | ) | 559 | |||||||||||||
| Adjusted EBITDA | $ | 37,199 | $ | (498 | ) | $ | (280 | ) | $ | (3,611 | ) | $ | 32,810 | |||||||
| (unaudited in thousands of US Dollars) | Conda | Arraias | Developmentandexploration | Corporate | Total | |||||||||||||||
| Operating income (loss) | $ | 31,372 | $ | (992 | ) | $ | (285 | ) | $ | (4,120 | ) | $ | 25,975 | |||||||
| Depreciation and depletion | 5,835 | 494 | 5 | 83 | 6,417 | |||||||||||||||
| Realized foreign exchange gain | (8 | ) | — | — | (9 | ) | (17 | ) | ||||||||||||
| Share-based payment expense | — | — | — | 435 | 435 | |||||||||||||||
| Impairments | — | — | — | — | — | |||||||||||||||
| Transaction costs | — | — | — | — | — | |||||||||||||||
| Adjusted EBITDA | $ | 37,199 | $ | (498 | ) | $ | (280 | ) | $ | (3,611 | ) | $ | 32,810 | |||||||
For the three months ended June 30, 2023, the Company had EBITDA and Adjusted EBITDA by segment as follows:
| (unaudited in thousands of US Dollars) | Conda | Arraias | Developmentandexploration | Corporate | Total | |||||||||||||||
| Net income (loss) | $ | 27,198 | $ | (924 | ) | $ | 87 | $ | (5,931 | ) | $ | 20,430 | ||||||||
| Finance (income) expense, net | 1,578 | (135 | ) | (5 | ) | 3,510 | 4,948 | |||||||||||||
| Current and deferred income tax expense (recovery) | 8,600 | — | — | (2,272 | ) | 6,328 | ||||||||||||||
| Depreciation and depletion | 7,198 | 732 | 2 | 48 | 7,980 | |||||||||||||||
| EBITDA | $ | 44,574 | $ | (327 | ) | $ | 84 | $ | (4,645 | ) | 39,686 | |||||||||
| Unrealized foreign exchange (gain) loss | — | (432 | ) | (342 | ) | 454 | (320 | ) | ||||||||||||
| Share-based payment expense | — | — | — | (98 | ) | (98 | ) | |||||||||||||
| Transaction costs | — | — | — | 453 | 453 | |||||||||||||||
| Other (income) expense, net | (7 | ) | (43 | ) | 6 | — | (44 | ) | ||||||||||||
| Adjusted EBITDA | $ | 44,567 | $ | (802 | ) | $ | (252 | ) | $ | (3,836 | ) | $ | 39,677 | |||||||
| (unaudited in thousands of US Dollars) | Conda | Arraias | Development and exploration | Corporate | Total | |||||||||||||||
| Operating income (loss) | $ | 37,357 | $ | (1,534 | ) | $ | (254 | ) | $ | (4,239 | ) | $ | 31,330 | |||||||
| Depreciation and depletion | 7,198 | 732 | 2 | 48 | 7,980 | |||||||||||||||
| Realized foreign exchange gain | 12 | — | — | — | 12 | |||||||||||||||
| Share-based payment expense | — | — | — | (98 | ) | (98 | ) | |||||||||||||
| Transaction costs | — | — | — | 453 | 453 | |||||||||||||||
| Adjusted EBITDA | $ | 44,567 | $ | (802 | ) | $ | (252 | ) | $ | (3,836 | ) | $ | 39,677 | |||||||
For the six months ended June 30, 2024 and 2023
For the six months ended June 30, 2024, the Company had EBITDA and Adjusted EBITDA by segment as follows:
| (unaudited in thousands of US Dollars) | Conda | Arraias | Developmentandexploration | Corporate | Total | |||||||||||||||
| Net income (loss) | $ | 51,983 | $ | (1,491 | ) | $ | (228 | ) | $ | (10,341 | ) | $ | 39,923 | |||||||
| Finance (income) expense, net | 2,387 | (458 | ) | 1 | 4,822 | 6,752 | ||||||||||||||
| Current and deferred income tax expense (recovery) | 13,770 | — | — | (4,392 | ) | 9,378 | ||||||||||||||
| Depreciation and depletion | 14,761 | 1,195 | 10 | 168 | 16,134 | |||||||||||||||
| EBITDA | $ | 82,901 | $ | (754 | ) | $ | (217 | ) | $ | (9,743 | ) | $ | 72,187 | |||||||
| Unrealized foreign exchange (gain) loss | — | 1,650 | (320 | ) | — | 1,330 | ||||||||||||||
| Share-based payment expense | — | — | — | 857 | 857 | |||||||||||||||
| Transaction costs | — | — | — | 227 | 227 | |||||||||||||||
| Non-recurring compensation expenses | — | — | — | 1,560 | 1,560 | |||||||||||||||
| Other (income) expense, net | 864 | (1,012 | ) | 4 | (40 | ) | (184 | ) | ||||||||||||
| Adjusted EBITDA | $ | 83,765 | $ | (116 | ) | $ | (533 | ) | $ | (7,139 | ) | $ | 75,977 | |||||||
| (unaudited in thousands of US Dollars) | Conda | Arraias | Developmentandexploration | Corporate | Total | |||||||||||||||
| Operating income (loss) | $ | 69,009 | $ | (1,311 | ) | $ | (543 | ) | $ | (9,942 | ) | $ | 57,213 | |||||||
| Depreciation and depletion | 14,761 | 1,195 | 10 | 168 | 16,134 | |||||||||||||||
| Realized foreign exchange loss | (5 | ) | — | — | (9 | ) | (14 | ) | ||||||||||||
| Share-based payment expense | — | — | — | 857 | 857 | |||||||||||||||
| Transaction costs | — | — | — | 227 | 227 | |||||||||||||||
| Non-recurring compensation expenses | — | — | — | 1,560 | 1,560 | |||||||||||||||
| Adjusted EBITDA | $ | 83,765 | $ | (116 | ) | $ | (533 | ) | $ | (7,139 | ) | $ | 75,977 | |||||||
For the six months ended June 30, 2023, the Company had EBITDA and Adjusted EBITDA by segment as follows:
| (unaudited in thousands of US Dollars) | Conda | Arraias | Developmentandexploration | Corporate | Total | |||||||||||||||
| Net income (loss) | $ | 55,183 | $ | (1,172 | ) | $ | 157 | $ | (5,531 | ) | $ | 48,637 | ||||||||
| Finance (income) expense, net | 3,280 | (271 | ) | 79 | 7,346 | 10,434 | ||||||||||||||
| Current and deferred income tax expense (recovery) | 17,016 | — | — | (14,870 | ) | 2,146 | ||||||||||||||
| Depreciation and depletion | 16,582 | 1,413 | 5 | 95 | 18,095 | |||||||||||||||
| EBITDA | $ | 92,061 | $ | (30 | ) | $ | 241 | $ | (12,960 | ) | 79,312 | |||||||||
| Unrealized foreign exchange (gain) loss | — | (508 | ) | (743 | ) | 942 | (309 | ) | ||||||||||||
| Share-based payment expense | — | — | — | 2,602 | 2,602 | |||||||||||||||
| Transaction costs | — | — | — | 1,164 | 1,164 | |||||||||||||||
| Other income | (24 | ) | (75 | ) | (32 | ) | — | (131 | ) | |||||||||||
| Adjusted EBITDA | $ | 92,037 | $ | (613 | ) | $ | (534 | ) | $ | (8,252 | ) | $ | 82,638 | |||||||
| (unaudited in thousands of US Dollars) | Conda | Arraias | Developmentandexploration | Corporate | Total | |||||||||||||||
| Operating income (loss) | $ | 75,445 | $ | (2,026 | ) | $ | (539 | ) | $ | (12,114 | ) | $ | 60,766 | |||||||
| Depreciation and depletion | 16,582 | 1,413 | 5 | 95 | 18,095 | |||||||||||||||
| Realized foreign exchange gain | 10 | — | — | 1 | 11 | |||||||||||||||
| Share-based payment expense | — | — | — | 2,602 | 2,602 | |||||||||||||||
| Transaction costs | — | — | — | 1,164 | 1,164 | |||||||||||||||
| Adjusted EBITDA | $ | 92,037 | $ | (613 | ) | $ | (534 | ) | $ | (8,252 | ) | $ | 82,638 | |||||||
As at June 30, 2024 and December 31, 2023
As at June 30, 2024, and December 31, 2023 the Company had trailing 12 months Adjusted EBITDA as follows:
| (unaudited in thousands of US Dollars) | June 30,2024 | December 31,2023 | ||||||||||
| For the three months ended June 30, 2024 | $ | 32,810 | $ | — | ||||||||
| For the three months ended March 31, 2024 | 43,167 | — | ||||||||||
| For the three months ended December 31, 2023 | 29,509 | 29,509 | ||||||||||
| For the three months ended September 30, 2023 | 19,655 | 19,655 | ||||||||||
| For the three months ended June 30, 2023 | — | 39,677 | ||||||||||
| For the three months ended March 31, 2023 | — | 42,961 | ||||||||||
| Trailing 12 months Adjusted EBITDA | $ | 125,141 | $ | 131,802 | ||||||||
TOTAL CAPEX
For the three months ended June 30, 2024 and 2023
For the three months ended June 30, 2024 the Company had capex by segment as follows:
| (unaudited in thousands of US Dollars) | Conda | Arraias | Developmentandexploration | Corporate | Total | |||||||||||||||
| Additions to property, plant and equipment | $ | 22,285 | $ | 1,906 | $ | (1 | ) | $ | 3 | $ | 24,193 | |||||||||
| Additions to mineral properties | 7,085 | — | 387 | — | 7,472 | |||||||||||||||
| Additions to property, plant and equipment related asset retirement obligations | (1,897 | ) | 589 | — | — | (1,308 | ) | |||||||||||||
| Additions to right-of-use assets | — | (179 | ) | 1 | — | (178 | ) | |||||||||||||
| Total capex | $ | 27,473 | $ | 2,316 | $ | 387 | $ | 3 | $ | 30,179 | ||||||||||
| Accrued capex | (11,009 | ) | — | — | — | (11,009 | ) | |||||||||||||
| Total cash capex | $ | 16,464 | $ | 2,316 | $ | 387 | $ | 3 | $ | 19,170 | ||||||||||
| Maintenance capex | $ | 20,297 | $ | 1,965 | $ | — | $ | 3 | $ | 22,265 | ||||||||||
| Accrued maintenance capex | (9,467 | ) | — | — | — | (9,467 | ) | |||||||||||||
| Cash maintenance capex | $ | 10,830 | $ | 1,965 | $ | — | $ | 3 | $ | 12,798 | ||||||||||
| Growth capex | $ | 7,176 | $ | 351 | $ | 387 | $ | — | $ | 7,914 | ||||||||||
| Accrued growth capex | (1,542 | ) | — | — | — | (1,542 | ) | |||||||||||||
| Cash growth capex | $ | 5,634 | $ | 351 | $ | 387 | $ | — | $ | 6,372 | ||||||||||
For the three months ended June 30, 2023, the Company had capex by segment as follows:
| (unaudited in thousands of US Dollars) | Conda | Arraias | Developmentandexploration | Corporate | Total | |||||||||||||||
| Additions to property, plant and equipment | $ | 1,889 | $ | 1,016 | $ | 25 | $ | — | $ | 2,930 | ||||||||||
| Additions to mineral properties | 12,768 | (1 | ) | 429 | — | 13,196 | ||||||||||||||
| Additions to property, plant and equipment related asset retirement obligations | 2,223 | (314 | ) | — | — | 1,909 | ||||||||||||||
| Additions to right-of-use assets | — | 42 | (25 | ) | — | 17 | ||||||||||||||
| Total capex | $ | 16,880 | $ | 743 | $ | 429 | $ | — | $ | 18,052 | ||||||||||
| Accrued capex | (4,548 | ) | — | — | — | (4,548 | ) | |||||||||||||
| Total cash capex | $ | 12,332 | $ | 743 | $ | 429 | $ | — | $ | 13,504 | ||||||||||
| Maintenance capex | $ | 10,548 | $ | 378 | $ | — | $ | — | $ | 10,926 | ||||||||||
| Accrued maintenance capex | (2,446 | ) | — | — | — | (2,446 | ) | |||||||||||||
| Cash maintenance capex | $ | 8,102 | $ | 378 | $ | — | $ | — | $ | 8,480 | ||||||||||
| Growth capex | $ | 6,332 | $ | 365 | $ | 429 | $ | — | $ | 7,126 | ||||||||||
| Accrued growth capex | (2,102 | ) | — | — | — | (2,102 | ) | |||||||||||||
| Cash growth capex | $ | 4,230 | $ | 365 | $ | 429 | $ | — | $ | 5,024 | ||||||||||
For the six months ended June 30, 2024 and 2023
For the six months ended June 30, 2024 the Company had capex by segment as follows:
| (unaudited in thousands of US Dollars) | Conda | Arraias | Developmentandexploration | Corporate | Total | |||||||||||||||
| Additions to property, plant and equipment | $ | 20,842 | $ | 3,015 | $ | (2 | ) | $ | 3 | $ | 23,858 | |||||||||
| Additions to mineral properties | 10,847 | — | 387 | — | 11,234 | |||||||||||||||
| Additions to asset retirement obligations | 1,090 | 766 | — | — | 1,856 | |||||||||||||||
| Additions to right-of-use assets | — | (341 | ) | 2 | — | (339 | ) | |||||||||||||
| Total capex | $ | 32,779 | $ | 3,440 | $ | 387 | $ | 3 | $ | 36,609 | ||||||||||
| Accrued capex | (13,063 | ) | — | — | — | (13,063 | ) | |||||||||||||
| Total cash capex | $ | 19,716 | $ | 3,440 | $ | 387 | $ | 3 | $ | 23,546 | ||||||||||
| Maintenance capex | $ | 20,716 | $ | 2,373 | $ | — | $ | 3 | $ | 23,092 | ||||||||||
| Accrued maintenance capex | (9,646 | ) | — | — | — | (9,646 | ) | |||||||||||||
| Cash maintenance capex | $ | 11,070 | $ | 2,373 | $ | — | $ | 3 | $ | 13,446 | ||||||||||
| Growth capex | $ | 12,063 | $ | 1,067 | $ | 387 | $ | — | $ | 13,517 | ||||||||||
| Accrued growth capex | (3,417 | ) | — | — | — | (3,417 | ) | |||||||||||||
| Cash growth capex | $ | 8,646 | $ | 1,067 | $ | 387 | $ | — | $ | 10,100 | ||||||||||
For the six months ended June 30, 2023, the Company had capex by segment as follows:
| (unaudited in thousands of US Dollars) | Conda | Arraias | Developmentandexploration | Corporate | Total | |||||||||||||||
| Additions to property, plant and equipment | $ | 10,140 | $ | 217 | $ | 25 | $ | 9 | $ | 10,391 | ||||||||||
| Additions to mineral properties | 13,462 | 880 | 501 | — | 14,843 | |||||||||||||||
| Additions to asset retirement obligations | (3,958 | ) | (370 | ) | — | — | (4,328 | ) | ||||||||||||
| Additions to right-of-use assets | — | 20 | (25 | ) | — | (5 | ) | |||||||||||||
| Total capex | $ | 19,644 | $ | 747 | $ | 501 | $ | 9 | $ | 20,901 | ||||||||||
| Accrued capex | (5,159 | ) | — | — | — | (5,159 | ) | |||||||||||||
| Total cash capex | $ | 14,485 | $ | 747 | $ | 501 | $ | 9 | $ | 15,742 | ||||||||||
| Maintenance capex | $ | 11,998 | $ | 378 | $ | — | $ | 9 | $ | 12,385 | ||||||||||
| Accrued maintenance capex | (2,719 | ) | — | — | — | (2,719 | ) | |||||||||||||
| Cash maintenance capex | $ | 9,279 | $ | 378 | $ | — | $ | 9 | $ | 9,666 | ||||||||||
| Growth capex | $ | 7,646 | $ | 369 | $ | 501 | $ | — | $ | 8,516 | ||||||||||
| Accrued growth capex | (2,440 | ) | — | — | — | (2,440 | ) | |||||||||||||
| Cash growth capex | $ | 5,206 | $ | 369 | $ | 501 | $ | — | $ | 6,076 | ||||||||||
NET DEBT AND NET LEVERAGE RATIO
As at June 30, 2024, and December 31, 2023 the Company had net debt and net leverage ratio as follows:
| (unaudited in thousands of US Dollars | June 30, | December 31, | ||||||
| except as otherwise noted) | 2024 | 2023 | ||||||
| Current debt | $ | 29,109 | $ | 29,127 | ||||
| Long-term debt | 37,439 | 61,441 | ||||||
| Cash and cash equivalents | (59,107 | ) | (30,753 | ) | ||||
| Deferred financing costs related to the Credit Facilities | 1,014 | 1,489 | ||||||
| Net debt | $ | 8,455 | $ | 61,304 | ||||
| Trailing 12 months Adjusted EBITDA | $ | 125,141 | $ | 131,802 | ||||
| Net leverage ratio | 0.1x | 0.5x | ||||||
LIQUIDITY
As at June 30, 2024, and December 31, 2023 the Company had liquidity as follows:
| June 30, | December 31, | |||||||
| (unaudited in thousands of US Dollars) | 2024 | 2023 | ||||||
| Cash and cash equivalents | $ | 59,107 | $ | 30,753 | ||||
| ABL Facility undrawn borrowing capacity | 41,413 | 40,000 | ||||||
| Liquidity | $ | 100,520 | $ | 70,753 | ||||
FREE CASH FLOW
For the three and six months ended June 30, 2024 and 2023, the Company had free cash flow as follows:
| For the three months ended June 30, | For the six months ended June 30, | |||||||||||||||
| (unaudited in thousands of US Dollars) | 2024 | 2023 | 2024 | 2023 | ||||||||||||
| Cash flows from operating activities | $ | 60,956 | $ | 52,538 | $ | 82,511 | $ | 73,610 | ||||||||
| Cash flows used by investing activities | (18,460 | ) | (13,505 | ) | (22,328 | ) | (15,743 | ) | ||||||||
| Free cash flow | $ | 42,496 | $ | 39,033 | $ | 60,183 | $ | 57,867 | ||||||||
CORPORATE SELLING, GENERAL, AND ADMINISTRATIVE EXPENSES
For the three and six months ended June 30, 2024 and 2023, the Company had corporate selling, general and administrative expenses as follows:
| For the three months ended June 30, | For the six months ended June 30, | |||||||||||||||
| (unaudited in thousands of US Dollars) | 2024 | 2023 | 2024 | 2023 | ||||||||||||
| Selling, general and administrative expenses | $ | 4,120 | $ | 4,239 | $ | 9,942 | $ | 12,114 | ||||||||
| Share-based payment expense | (435 | ) | 98 | (857 | ) | (2,602 | ) | |||||||||
| Corporate selling, general and administrative expenses | $ | 3,685 | $ | 4,337 | $ | 9,085 | $ | 9,512 | ||||||||
1 Adjusted EBITDA, trailing 12 months Adjusted EBITDA, total capex, net debt, net leverage ratio and free cash flow are each a non-IFRS financial measure. For additional information on non-IFRS and other financial measures, see “Non-IFRS financial measures” below. International Financial Reporting Standards (“IFRS”).
2 Sales volumes reflect quantity in P2O5 of Conda sales projections.
3 Corporate selling, general and administrative expenses, maintenance capex, and growth capex are each non-IFRS financial measures. For additional information on non-IFRS and other financial measures, see “Non-IFRS financial measures” below.
4 Liquidity is a non-IFRS financial measure. For additional information on non-IFRS and other financial measures, see “Non-IFRS financial measures” below.
1 Year Itafos Chart |
1 Month Itafos Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
